Ferring Pharmaceuticals, Custom Ultrasonics & more — 5 GI company key notes

Here are five updates on GI companies from the past week.

Advertisement

Ferring Pharmaceuticals agreed to acquire Rebiotix for an unspecified sum.

The FDA approved Custom Ultrasonics’ 83 Plus Automated Endoscope Reprocessors for use in healthcare facilities to wash and disinfect flexible endoscopes, duodenoscopes and scope accessories between uses.

Perrigo and Dexcel Pharma Technologies launched Omeprazole Delayed Release Orally Disintegrating Tablets, an over-the-counter medication to treat heartburn.

Chang-Hee Kim, PhD, of GoDx, won the 2018 AGA Shark Tank held at the 2018 AGA Tech Summit, March 21 to March 23 in Boston. Read more.

Becker’s ASC Review profiled Boston Scientific.

More articles on gastroenterology: 
8 hospitals, health systems opening or planning ASCs
NueHealth shakes up leadership team & more — 9 ASC company key notes
Pain Specialists of Southern Oregon to open new ASC: 4 key points.

Advertisement

Next Up in GI & Endoscopy

  • Below is a list of five gastroenterology leaders in the U.S. who have made a positive impact on their organizations…

  • Chicago-based GI Partners of Illinois saw its GI case mix tilt toward more complex, chronic and multidisciplinary care in 2025,…

Advertisement

Comments are closed.